Early Onset Neonatal Group B Streptococcal Sepsis

Abstract

Early onset neonatal group B streptococcal (GBS) sepsis is a serious neonatal illness with high morbidity and mortality. The disease can present in two forms: early clinical manifestation with respiratory distress soon after birth or late presentation with gradual onset of signs of sepsis. The former carries a high risk for serious cardiovascular complication with persistent pulmonary hypertension; the latter is often complicated with meningitis that may lead to serious neurodevelopmental impairment. An important advance in the past three decades is the development and implementation of preventive strategy for this disease by universal screening and identification of maternal GBS carriers and/or risk factors with subsequent use of intrapartum antibiotic prophylaxis. The strategy has resulted in a significant reduction of the disease from 1.5 to 0.3/1,000 live births over the past three decades. Some women may have unknown GBS status. The American Academy of Pediatrics has developed an algorithm as guidance for the management of the newborns.

Keywords

neonatal sepsis - chorioamnionitis - intrapartum antibiotic prophylaxis - GBS screening

• References

• 1 Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986; 314: 1665-1669
• 2 Schuchat A, Oxtoby M, Cochi S , et al. Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta. J Infect Dis 1990; 162: 672-677
• 3 Schuchat A, Deaver-Robinson K, Plikaytis BD, Zangwill KM, Mohle-Boetani J, Wenger JD. The Active Surveillance Study Group. Multistate case-control study of maternal risk factors for neonatal group B streptococcal disease. Pediatr Infect Dis J 1994; 13: 623-629
• 4 Schuchat A, Zywicki SS, Dinsmoor MJ , et al. Risk factors and opportunities for prevention of early-onset neonatal sepsis: a multicenter case-control study. Pediatrics 2000; 105 (1 Pt 1) 21-26
• 5 Wiswell TE, Baumgart S, Gannon CM, Spitzer AR. No lumbar puncture in the evaluation for early neonatal sepsis: will meningitis be missed?. Pediatrics 1995; 95: 803-806
• 6 Hendricks-Muñoz KD, Shapiro DL. The role of the lumbar puncture in the admission sepsis evaluation of the premature infant. J Perinatol 1990; 10: 60-64
• 7 Libster R, Edwards KM, Levent F , et al. Long-term outcomes of group B streptococcal meningitis. Pediatrics 2012; 130: e8-e15
• 8 Lim DV, Morales WJ, Walsh AF, Kazanis D. Reduction of morbidity and mortality rates for neonatal group B streptococcal disease through early diagnosis and chemoprophylaxis. J Clin Microbiol 1986; 23: 489-492
• 9 Tuppurainen N, Hallman M. Prevention of neonatal group B streptococcal disease: intrapartum detection and chemoprophylaxis of heavily colonized parturients. Obstet Gynecol 1989; 73: 583-587
• 10 Garland SM, Fliegner JR. Group B streptococcus (GBS) and neonatal infections: the case for intrapartum chemoprophylaxis. Aust N Z J Obstet Gynaecol 1991; 31: 119-122
• 11 Matorras R, García-Perea A, Omeñaca F, Diez-Enciso M, Madero R, Usandizaga JA. Intrapartum chemoprophylaxis of early-onset group B streptococcal disease. Eur J Obstet Gynecol Reprod Biol 1991; 40: 57-62
• 12 CDC. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR 1996; 45 (No. RR-7)
• 13 Yancey MK, Schuchat A, Brown LK, Ventura VL, Markenson GR. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet Gynecol 1996; 88: 811-815
• 14 American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. Pediatrics 1997; 99: 489-496
• 15 Committee on Obstetric Practice. American College of Obstetrics and Gynecologists. ACOG committee opinion. Prevention of early-onset group B streptococcal disease in newborns. Number 173—June 1996. Int J Gynaecol Obstet 1996; 54: 197-205
• 16 Centers for Disease Control and Prevention (CDC). Hospital-based policies for prevention perinatal group B streptococcal disease—United States, 1999. MMWR Morb Mortal Wkly Rep 2000; 49: 936-940
• 17 Schrag SJ, Zell ER, Lynfield R , et al; Active Bacterial Core Surveillance Team. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 2002; 347: 233-239
• 18 CDC. Prevention of perinatal group B streptococcal disease: revised guidelines from CDC. MMWR 2002; 51 (No. RR-11)
• 19 CDC. Prevention of perinatal group B streptococcal disease: revised guidelines from CDC. 2010 59. 1-36
• 20 Carstensen H, Christensen KK, Grennert L, Persson K, Polberger S. Early-onset neonatal group B streptococcal septicaemia in siblings. J Infect 1988; 17: 201-204
• 21 de Cueto M, Sanchez MJ, Sampedro A, Miranda JA, Herruzo AJ, Rosa-Fraile M. Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus. Obstet Gynecol 1998; 91: 112-114
• 22 Davies HD, Miller MA, Faro S, Gregson D, Kehl SC, Jordan JA. Multicenter study of a rapid molecular-based assay for the diagnosis of group B streptococcus colonization in pregnant women. Clin Infect Dis 2004; 39: 1129-1135
• 23 Atkins KL, Atkinson RM, Shanks A, Parvin CA, Dunne WM, Gross G. Evaluation of polymerase chain reaction for group B streptococcus detection using an improved culture method. Obstet Gynecol 2006; 108 (3 Pt 1) 488-491
• 24 Edwards RK, Novak-Weekley SM, Koty PP, Davis T, Leeds LJ, Jordan JA. Rapid group B streptococci screening using a real-time polymerase chain reaction assay. Obstet Gynecol 2008; 111: 1335-1341
• 25 Baker CJ, Rench MA, Edwards MS, Carpenter RJ, Hays BM, Kasper DL. Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus. N Engl J Med 1988; 319: 1180-1185
• 26 Heath PT, Feldman RG. Vaccination against group B streptococcus. Expert Rev Vaccines 2005; 4: 207-218
• 27 Edwards MS. Group B streptococcal conjugate vaccine: a timely concept for which the time has come. Hum Vaccin 2008; 4: 444-448
• 28 Baker CJ, Byington CL, Polin RA. Committee on Infectious Diseases; Committee on Fetus and Newborn. Policy statement—Recommendations for the prevention of perinatal group B streptococcal (GBS) disease. Pediatrics 2011; 128: 611-616
• 29 Lieberman E, Lang JM, Frigoletto Jr F, Richardson DK, Ringer SA, Cohen A. Epidural analgesia, intrapartum fever, and neonatal sepsis evaluation. Pediatrics 1997; 99: 415-419
• 30 Ottolini MC, Lundgren K, Mirkinson LJ, Cason S, Ottolini MG. Utility of complete blood count and blood culture screening to diagnose neonatal sepsis in the asymptomatic at risk newborn. Pediatr Infect Dis J 2003; 22: 430-434
• 31 Escobar GJ, Li DK, Armstrong MA , et al. Neonatal sepsis workups in infants >/= 2000 grams at birth: a population-based study. Pediatrics 2000; 106 (2 Pt 1) 256-263